19.06.2018 • NewsChinaDede WillamsHIV drug

China Develops new HIV Drug

China Develops new HIV Drug (c) Frontier
China Develops new HIV Drug (c) Frontier

Albuvirtide, a new drug developed by Frontier Biotechnologies in China, is claimed to be the world's first long-acting fusion inhibitor for HIV. It works by blocking the fusion between the virus and the host cell membranes, interrupting the virus's life cycle before it has begun to do harm.

What makes this treatment more attractive to patients, Chinese reports said, is that unlike many other drugs on the market it has to be injected only once a week. According to the Xinhua news agency, Albuvirtide also has been shown to have fewer side effects, particularly on the liver, compared to current treatments in China.

All HIV treatments available in the People’s Republic are imported or generic, and patients typically take a daily cocktail of pills. Xie Dong, chief scientist and former head of Frontier Biotechnologies, told Xinhua that China's first domestically developed HIV drug offers patients a new treatment option. “We hope to dispel the fact that China has not developed good anti-AIDS medicine,” he added.

While the new drug is expected to improve patient compliance, reduce costs and improve patient quality of life, Pend Xiaohui, a sexologist at Central China Normal University, told the newspaper Global Times that patients will have to overcome the psychological obstacle of injecting the medicine on their own, or have a doctor do it for them.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.